secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cingulate Inc. (CING)
CIK:        0001862150
Form:       8-K
Filed at:   2026-02-17T23:59:59+00:00
Accession:  0001493152-26-006942
Event type: other_material
Sentiment:  positive
Materiality: 0.90
Item codes: 3.02, 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Cingulate closes $12M PIPE financing, appoints Jeff Hargroves to board and converts debt
--------------------------------------------------------------------------------

- Cingulate completed $12M private placement led by Falcon Creek Capital at $5.04 per share with 80% warrant coverage
- Jeff Hargroves appointed as Class I director and to Audit, Compensation, and Nominating committees
- Company issued 25,786 shares at $6.16 per share to a lender in exchange for debt under Section 3(a)(9)
- All PIPE investors subject to 180-day lock-up; total potential proceeds up to $21.4 million
- FDA PDUFA target date for CTx-1301 ADHD treatment set for May 31, 2026

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1862150/000149315226006942/0001493152-26-006942-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1862150/000149315226006942/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-006942

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer